Arthritis Research & Therapy

official impact factor 4.36

This article is part of the supplement: Current and new antitumor necrosis factor agents in perspective

Highly Access Email this article to a friend

Effective use of TNF antagonists

David Yocum

Arthritis Res Ther 2004, 6(Suppl 2):S24-S30 doi:10.1186/ar997

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.